PRS55 - COST-EFFECTIVENESS OF MEPOLIZUMAB IN SEVERE EOSINOPHILIC ASTHMA PATIENTS IN FRANCE

Autor: Maunoury, F., Pribil, C., Aubier, M., Nachbaur, G., Doyle, S.
Zdroj: In Value in Health October 2018 21 Supplement 3:S413-S413
Databáze: ScienceDirect